
The Grob Tea Company Approves Q1 Unaudited Results; Announces Committee Reconstitution and Director Resignation
The Grob Tea Company Limited announced several key outcomes following its Board meeting held on August 12, 2026. Key decisions included the approval of un-audited financial results for the quarter ended June 30, 2026, the endorsement of the Cost Audit Report, and the announcement of changes in the composition of various Board committees. The company also noted the resignation of Mr. Niraj Kumar Harodia from his position as an Independent Director.Financial Approvals and Operational Decisions
The Board approved the Un-Audited Financial Results for the quarter ending June 30, 2026, along with a Limited Review Report conducted by B Nath & Co., Chartered Accountants. Additionally, the Board considered and approved the Cost Audit Report for the financial year 2025-2026, prepared by M/s Dipak Lal & Associates.Furthermore, the company proposed and approved Inter Corporate Deposits and Other Loans intended for the Financial Year 2026-2027, which had been recommended by the Audit Committee and sanctioned by the Finance Committee.
Leadership Changes
The Board took note of and accepted the resignation of Mr. Niraj Kumar Harodia (DIN: 06676837), an Independent Director of The Grob Tea Company Limited. His resignation was effective from the close of business hours on August 12, 2026, following a letter received on August 10, 2026. Mr. Harodia stated that his resignation was due to personal reasons and other commitments.Committee Reconstitution
In light of changes in the Board composition, the Board of Directors approved the reconstitution of several key committees, effective from August 13, 2026. The reconstituted committees are as follows:| Committee | Members |
|---|---|
| Audit Committee | Kishan Kejriwal (Chairman), Nirmal Kumar Goyal (Member), Nidhi Shah (Member), Pradeep Kumar Agarwal (Member) |
| Nomination and Remuneration Committee | Kishan Kejriwal (Chairman), Nirmal Kumar Goyal (Member), Nidhi Shah (Member) |
| Independent Director's Committee | Kishan Kejriwal (Chairman), Nirmal Kumar Goyal (Member), Nidhi Shah (Member) |
Quarterly Financial Snapshot
The company released the Un-Audited Statement of Financial Results for the Quarter Ended June 30, 2026, which were reviewed and approved by the Board. The financial performance is presented below along with comparative figures:| Particulars | Quarter ended 30/06/2026 | Quarter ended 31/03/2026 | Q3 30/06/2025 | Q1 31/03/2026 |
|---|---|---|---|---|
| Revenue from operations | 2,285.59 | 975.66 | 1,785.20 | 11,437.78 |
| Total Income | 2,450.72 | 1,141.62 | 1,997.75 | 12,089.49 |
| Profit/(Loss) before exceptional items and tax | 2,123.87 | 2,858.73 | 1,862.36 | 11,330.05 |
| Tax expense | 326.85 | (1,717.11) | - | 759.44 |
| Profit after tax | 1,862.36 | (717.11) | 1,862.36 | 10,530.02 |
The company's management noted that the financial results were prepared in accordance with Ind AS notified under Companies (Indian Accounting Standard) Rules, 2015. The leadership also confirmed that the company had acquired a Wholly Owned Subsidiary via a Share Purchase Agreement dated July 1, 2026, from the existing shareholders of Bazaloni Group Limited, which was completed on July 28, 2026, for an investment of 72.16 Cr.
GROBTEA Stock Price Movement
The Grob Tea Company Limited shares edged higher on Wednesday, gaining 2.23% as the stock settled at ₹919.60. The equity saw vigorous buying activity across 1,109 shares traded and within a trading range spanning from ₹895 to ₹991 during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.